John Frederick

Board Member

Equibles does not estimate personal net worth.

About John Frederick

John Frederick is recorded as Board Member at Tempest Therapeutics, Inc. (TPST) since October 13, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed October 19, 2026 that John Frederick was appointed Class III director of the Board, effective October 13, 2026. Tempest Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tempest Therapeutics, Inc. includes Julia C. Owens (CEO and Chairman), Louis J. Arcudi III (CEO, CFO and Board Member), Matt Angel (CEO and Board Member) and 7 others.

“Effective October 13, 2026, the Board of Directors (the “Board”) of Tempest Therapeutics, Inc. (the “Company”) appointed Mr. John Frederick as a Class III director of the Board.”

Tempest Therapeutics, Inc. Form 8-K, filed October 19, 2026 · Read the filing

Affiliation history

Tempest Therapeutics, Inc. (TPST)
Board Member

SEC 8-K

Current
2026-10-13–present

Company network

Tempest Therapeutics, Inc.

TPST

Current role

Biotechnology · Healthcare

Board Member

2026-10-13–present

Leadership on record at Tempest Therapeutics, Inc.

Julia C. Owens CEO, Chairman
Louis J. Arcudi III CEO, CFO, Board Member
Matt Angel CEO, Board Member
Matt Angel, Ph.D. CEO, Board Member
Stephen R. Brady CEO
Mike Raab Chairman, Board Member
Stephen Brady Chairman
Constance Ames CFO
Jennifer Minai-Azary CFO
Justin Trojanowski CFO, Chief Accounting Officer

Recent activity

Executive change Appointed: Class III director of the Board Tempest Therapeutics, Inc. (TPST)
2026-10-13